Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004872 · ClinicalTrials.gov registry record · Phase 1
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004872 is a Phase 1 study that has completed, run by University of Wisconsin, Madison.
The verdict
NCT00004872, a Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Endostatin may stop the growth of solid tumors by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of endostatin in treating patients who have advanced refractory solid tumors.
Interventions
- BIOLOGICAL recombinant human endostatin
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004872
The ClinicalTrials.gov registry entry for NCT00004872 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which recombinant human endostatin is the first listed.
NCT00004872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004872 about?
NCT00004872 is a clinical study titled "Endostatin in Treating Patients With Advanced Refractory Solid Tumors". RATIONALE: Endostatin may stop the growth of solid tumors by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of endostatin in treating patients who have advanced refractory solid tumors.
What is the current status of trial NCT00004872?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-03.
What interventions are being tested in trial NCT00004872?
The interventions under investigation include: recombinant human endostatin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00004872?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.